$10.10
0.020.20%
At close: -
$10.07
-0.03-0.30%
After Hours: Mar 13, 4:02 PM EDT
Comments
Loading...
Translational Development Analyst Ratings and Price Targets | NASDAQ:TDAC | Benzinga
Translational Development Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Translational Development Corp from these most-recent analyst ratings.
Analyst Ratings for Translational Development
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Translational Development (TDAC) stock?
There is no price target for Translational Development
What is the most recent analyst rating for Translational Development (TDAC)?
There is no analyst for Translational Development
When was the last upgrade for Translational Development (TDAC)?
There is no last upgrade for Translational Development
When was the last downgrade for Translational Development (TDAC)?
There is no last downgrade for Translational Development.
When is the next analyst rating going to be posted or updated for Translational Development (TDAC)?
There is no next analyst rating for Translational Development.
Is the Analyst Rating Translational Development (TDAC) correct?
There is no next analyst rating for Translational Development.
Browse analyst ratings and price targets on all stocks.